BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26876575)

  • 1. MicroRNA-218 promotes high glucose-induced apoptosis in podocytes by targeting heme oxygenase-1.
    Yang H; Wang Q; Li S
    Biochem Biophys Res Commun; 2016 Mar; 471(4):582-8. PubMed ID: 26876575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
    Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
    Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
    Liu WT; Peng FF; Li HY; Chen XW; Gong WQ; Chen WJ; Chen YH; Li PL; Li ST; Xu ZZ; Long HB
    Cell Death Dis; 2016 Nov; 7(11):e2477. PubMed ID: 27882943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
    Wang L; Li H
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
    Sun J; Li ZP; Zhang RQ; Zhang HM
    Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salidroside Reduces High-Glucose-Induced Podocyte Apoptosis and Oxidative Stress via Upregulating Heme Oxygenase-1 (HO-1) Expression.
    Lu H; Li Y; Zhang T; Liu M; Chi Y; Liu S; Shi Y
    Med Sci Monit; 2017 Aug; 23():4067-4076. PubMed ID: 28831032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions.
    Lee SC; Han SH; Li JJ; Lee SH; Jung DS; Kwak SJ; Kim SH; Kim DK; Yoo TH; Kim JH; Chang SH; Han DS; Kang SW
    Kidney Int; 2009 Oct; 76(8):838-48. PubMed ID: 19657327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.
    Long J; Wang Y; Wang W; Chang BH; Danesh FR
    J Biol Chem; 2011 Apr; 286(13):11837-48. PubMed ID: 21310958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29a enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis by targeting heme oxygenase-1.
    Fan WX; Wen XL; Xiao H; Yang QP; Liang Z
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8909-8917. PubMed ID: 30575934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-29b Alleviates High Glucose-induced Inflammation and Apoptosis in Podocytes by Down-regulating PRKAB2.
    Du H; Wang Y; Zhu Y; Li X; Zhu T; Wu Q; Zha F
    Endocr Metab Immune Disord Drug Targets; 2024; 24(8):981-990. PubMed ID: 38204237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Linc 4930556M19Rik Suppresses High Glucose-Triggered Podocyte Apoptosis, Fibrosis and Inflammation via the miR-27a-3p/Metalloproteinase 3 (TIMP3) Axis in Diabetic Nephropathy.
    Fan H; Zhang W
    Med Sci Monit; 2020 Sep; 26():e925361. PubMed ID: 32896839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis.
    Dong C; Zheng H; Huang S; You N; Xu J; Ye X; Zhu Q; Feng Y; You Q; Miao H; Ding D; Lu Y
    Exp Cell Res; 2015 Oct; 337(2):146-59. PubMed ID: 25882498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4.
    Xu Y; Zhang J; Fan L; He X
    Biochem Biophys Res Commun; 2018 Oct; 505(2):339-345. PubMed ID: 30245133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A.
    Fu Y; Wang C; Zhang D; Chu X; Zhang Y; Li J
    J Cell Physiol; 2019 Nov; 234(11):20869-20878. PubMed ID: 31025335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.